Product Information

AMLODIPINE-ATORVAST 5-80 MG is a generic product labeled by Apotex Corp., priced at $1.5864 per EA under NDC 60505349203. Its NADAC has been published 135 times since Apr 17, 2024.

FDA first approved this application on Nov 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 5-80 MG

Amlodipine and Atorvastatin
$1.5864per EA

Strength

5; 80 mg/1; mg/1

Manufacturer

Apotex Corp.

NDC

60505349203

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205199

FDA Approved

11/18/2019

TE Code

AB

On Market Since

7/29/2020

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 5-80 MG has been published 135 times since Apr 17, 2024, and over the history we have for it it has declined 38.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5864 per EA
All-time high$2.8129 (Apr 16, 2025)
All-time low$1.4143 (May 20, 2026)
52-week high$2.4951
52-week low$1.4143
Median price$2.5025
Average price$2.2750
Largest weekly change-13.4% (Feb 18, 2026)
Weeks tracked135
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

+1.8%

3M

+9.5%

6M

+6.0%

1Y

-36.0%

3Y

N/A

5Y

N/A

All

-38.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 5-80 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-80 MG, manufactured by Apotex Corp., is $1.5864 per EA (NDC 60505349203), effective Nov 11, 2026.

How has the price of AMLODIPINE-ATORVAST 5-80 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-80 MG has declined 38.6%. It has been tracked across 135 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-80 MG?

Since Apr 17, 2024, the NADAC for AMLODIPINE-ATORVAST 5-80 MG has ranged from a low of $1.4143 (May 20, 2026) to a high of $2.8129 (Apr 16, 2025), with a median of $2.5025 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-80 MG?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 5-80 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-ATORVAST 5-80 MG?

AMLODIPINE-ATORVAST 5-80 MG (NDC 60505349203) is labeled by Apotex Corp., and CMS classifies it as a generic product.